- Global Pharma News & Resources

Drug Eluting Stents Market Expanding At A CAGR Of 8.9%, Reaching USD 5.3 billion by 2025 |

Pune, Maharashtra, India, October 7 2022 (Wiredrelease) Prudour Pvt. Ltd –:The global drug eluting stents market is expected to reach USD 5.3 billion by 2025, according to a new report by The market is anticipated to witness a CAGR of 8.9% over the forecast period.

The rising prevalence of cardiovascular diseases and technological advancements are expected to drive market growth over the forecast period 2022-2032. In addition, favorable reimbursement policies in developed countries are also expected to contribute to market growth. However, stringent regulations regarding product approvals are expected to hamper market growth over the forecast period. The drug-eluting stents market is segmented on the basis of product type, application, end user, and geography.

In FY 2022, According to our researcher latest study, The [200+ Research Pages Report] Drug Eluting Stents Market report covers an in-depth analysis of market dynamics, business models, segmental/regional analysis, and respective market shares and strategies adopted by key market players operating in the world. The research report aims to provide an unbiased and comprehensive outlook of the global Drug Eluting Stents market to the readers. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.

To understand how our report can bring difference to your business strategy, Ask for a brochure –

*Get Sample Report (#PDF) sent to your email within minutes*

Global Drug Eluting Stents Market: Drivers and Restrains

The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones

Key Take-Away

Competition mapping

Role of key players across the value chain

End-user analysis to define market strategy

Industry trends, opportunities and challenges in the market

Regional and Country breakdown by macro and microeconomic factors

Key Market Segments

Cobalt-chromium alloy Stents
Magnesium alloy Stents
Tyrosine polycarbonate Stents
Nitinol Stents
Platinum chromium alloy Stents
Stainless steel Stents


Coronary Heart Disease

Key Market Players included in the report:

Abbott Vascular
Advantec Vascular
Blue Medical
Boston Scientific
DISA Vascular
Medtronic Vascular
B.Braun Melsengen AG
MicroPort Medical
MIV Therapeutics
Promed Medical
Relisys Medical
Reva Medical
Sino Medical
Terumo Medical

For Instant Purchase:

The content of this report includes 15+ chapters:

1. Drug Eluting Stents Market Product Overview

2. Research Methodology verified by

3. Impact of COVID-19 on Global Drug Eluting Stents Market

4. Voice of Customer

5. Executive Summary

6. Global Drug Eluting Stents Market Outlook

7. Asia-Pacific Drug Eluting Stents Market Outlook

8. Europe Drug Eluting Stents Market Outlook

9. North America Drug Eluting Stents Market Outlook

10. South America Drug Eluting Stents Market Outlook

11. Middle East and Africa Drug Eluting Stents Market Outlook

12. Market Dynamics

13. Market Trends and Developments

14. Pricing Analysis

15. Competitive Landscape

16. Strategic Recommendations

17. Companies Mentioned

Access Full Report Description with TOC @

This content has been published by Prudour Pvt. Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 07-Oct-2022